Ami Organics IPO, Vijaya Diagnostic IPO CLOSE today: Day 2 subscription data! Should you apply or not? Check What Market Guru Anil Singhvi RECOMMENDED

The Initial Public Offerings (IPO) of Ami Organics, which opened on Wednesday September 1, 2021, continue to see good response as the issue was subscribed 3.90 times at the end of the second day on Thursday. Ami IPO issue saw bids being made for 2,55,07,200 shares in total as against quota of 65,42,342 shares, with one day remaining for the issue, showed NSE bid details. Retail Individual Investors (RIIs) were leading the subscription by subscribing the issue 6.32 times with bids for 2,07,46,632 against reserved quota of 32,81,723 shares for retail investors. Qualified Institutional Buyers (QIBs) and Non-Institutional Investors (NIIs) subscribed the issue 1.43 times and 1.51 times respectively.  

See Zee Business Live TV Streaming Below:

Another IPO that opened on the same day—Vijaya Diagnostic — however saw lukewarm response even on Day 2 of the opening of the issue. Vijaya Diagnostic IPO witnessed 0.47 times subscription with none of the portion being fully subscribed. As per NSE consolidated bid details, RIIs, NIIs, QIBs and employees' portions were subscribed 0.74 times, 0.05 times, 0.32 times and 0.52 times respectively as on Thursday. 

The Initial Public Offerings (IPO) of Ami Organics and Vijaya Diagnostic will close on Friday, September 3, 2021.  

Ami Organics, Vijaya Diagnostic Business Profile

Ami Organics is a specialty chemicals firm, which focuses on the pharma industry. It is known for developing a wide array of pharma medicine across 17 key therapeutic areas i.e. anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant, and anti-coagulant. Ami Organics IPO comprises Rs 200 crore fresh fund raise and Rs 370 crore secondary share sale. The price band for its IPO is Rs 603-610 per share.  

Vijaya Diagnostic claims to be the largest diagnostic chains in southern India. Vijaya Diagnostic IPO is entirely secondary share sale worth Rs 1,894 crore. Vijaya Diagnostic  has kept the price band at Rs 522 to 531 per share.  

Anil Singhvi Recommendation on Ami Organics, Vijaya Diagnostic IPOs 

Earlier, talking about Ami Organics IPO, Zee Business Managing Editor Anil Singhvi has recommended to apply with long-term objective. “The recent Issues failed to show bumper listings despite being oversubscribed, while those who didn’t get subscribed much had the good listing. Hence one should keep a long-term view as the September series could be a little volatile too," Anil Singhvi had said.  

Singhvi had similar view regarding Vijaya Diagnostic Centre IPO. "The investors must apply in Vijaya Diagnostic Centre IPO with a long-term view," Zee Business Managing Editor has said.